Skip to main content

Table 1 Primary and secondary antibodies used in the study

From: Repetitive mild TBI causes pTau aggregation in nigra without altering preexisting fibril induced Parkinson’s-like pathology burden

 

Species

Type

Dilution

Vendor

Catalog #

Lot #

Primary antibody

 TH

Chicken

Polyclonal

1–1000

Millipore

AB9702

3519393

 NeuN

Mouse

Monoclonal

1–1000

Novus

NBP1-92693

D102247

 IBA1

Rabbit

Polyclonal

1–1000

Wako

019-19741

CAE1308

 MHC II

Mouse

Monoclonal

1–500

BD

BDB554926

1137896

 GFAP

Chicken

Polyclonal

1–1000

EnCor

CPCA-GFAP

7529-5

 pSyn

Rabbit

Monoclonal

1–1000

Abcam

ab51253

GR3232346-6

 pTau (AT8)

Mouse

Monoclonal

1–2000

ThermoFisher

MN1020

WJ3381064

 s100Beta

Rabbit

Monoclonal

1–1000

Abcam

Ab54642

GR3215095-29

 s100Beta

Rabbit

Monoclonal

1–1000

Novus

NBP2-53188

6285-4P10803

 s100Beta

Mouse

Monoclonal

1–1000

ProteinTech

6616-Ig

10004814

Secondary antibody

 Alexa 488 anti-rabbit

Goat

Polyclonal

1–1000

Invitrogen

A32721

UD282059

 Alexa 555 anti-chicken

Goat

Polyclonal

1–1000

Invitrogen

A21437

2352144

 Alexa 647 anti-mouse

Goat

Polyclonal

1–1000

Invitrogen

A32728

UD279293

 IRDye 680RD anti-rabbit

Donkey

Polyclonal

1–10,000

LICOR

925-68073

C90129-11

 IRDye 800CW anti-mouse

Donkey

Polyclonal

1–10,000

LICOR

926-32212

D20126-04

 HRP anti-rabbit

Goat

Polyclonal

1–1000

Cell signaling

7074P2

31

 HRP anti-mouse

Goat

Polyclonal

1–2000

Invitrogen

62-6520

UA281872

  1. The antibodies were internally validated, and optimal concentrations determined